Vanguard Group Inc Aquestive Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,263,796 shares of AQST stock, worth $20.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,263,796
Previous 4,227,672
0.85%
Holding current value
$20.1 Million
Previous $11 Million
93.19%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
46.8MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$46.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$26.2 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$25.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$13 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.8MShares$8.46 Million1.4% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $251M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...